BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 487742)

  • 1. Prednimustine for prostate cancer therapy.
    Slack NH; Murphy GP
    Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
    J Urol; 1979 Jun; 121(6):763-5. PubMed ID: 458947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
    Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
    Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
    Boesen E; Mouridsen HT
    Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednimustine: the rationale for clinical development.
    Schein PS; Cavalli F
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-2. PubMed ID: 3952515
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
    Trans Am Assoc Genitourin Surg; 1978; 70():69-71. PubMed ID: 753026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of prednimustine in glioblastoma multiforme.
    Andersen J; Christensen L; Kongsholm H
    Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednimustine in advanced breast cancer: a review.
    Mouridsen HT
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences in tumor-oriented anti-cancer drugs].
    Ohsawa N
    Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):313-7. PubMed ID: 2841390
    [No Abstract]   [Full Text] [Related]  

  • 14. Prednimustine in elderly patients with multiple myeloma: a phase II study.
    Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
    Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
    [No Abstract]   [Full Text] [Related]  

  • 15. Prednimustine in advanced malignant melanoma: a phase II study.
    Pedersen L; Løber J; Dalmark M; Mouridsen HT
    Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
    [No Abstract]   [Full Text] [Related]  

  • 16. Prednimustine in adult acute myeloid leukaemia.
    Brandt L; Könyves I
    Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
    Jensen HS; Hansen HH; Dombernowsky P
    Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with estramustine phosphate and predinimustine, two steroidal alkylating agents compounds [proceedings].
    Catane R
    Cancer Treat Rep; 1978 Aug; 62(8):1264-5. PubMed ID: 688269
    [No Abstract]   [Full Text] [Related]  

  • 19. Prednimustine.
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
    [No Abstract]   [Full Text] [Related]  

  • 20. [A phase II study of prednimustine in advanced ovarian cancer].
    Grundsell H; Johnsson JE; Tropé C
    Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.